Objectives This study assessed the spatial distribution of HIV test non-uptake among pregnant women who attended antenatal care (ANC) in sub-Saharan Africa. Setting Sub-Saharan Africa (SSA) region.
24 SSA countries were included in this study. Participants 82 397 women who were pregnant in the last 2 years preceding the survey.
Outcome measure HIV test non-uptake, which is a legacy indicator of HIV test among pregnant women. Result The HIV test non-uptake among ANC attending pregnant women was 39.6% (95% CI 39.27% to 39.93%).
The spatial autocorrelation test revealed that HIV testing non-uptake among pregnant women was clustered. The global Moran’s I value was 0.48 with a p value <0.01.
Hotspot areas were those with high rates of HIV testing non-uptake. These hotspot areas were located in most parts of Mali, Mauritania, Madagascar, Guinea, Senegal, central parts of Angola, eastern part of Senegal and northern parts of Ethiopia.
BMJ Open published a clinical update in Research Highlights on 08 Jun 2026.
The item focuses on Spatial variation in HIV test non-uptake among antenatal care-attending pregnant women in sub-Saharan Africa: a cross-sectional study using demographic and health survey data.
Review the original article for the full source wording and details.